Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:1/12/2009

Fourth Quarter & Full Year 2008 Earnings Conference Call

Thursday, February 12, 2009, 5:00 p.m. U.S. EST

FRAZER, Pa., Jan. 12 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering fourth quarter and full year 2008 results for 5:00 p.m. EST on Thursday, February 12, 2009.

February 12, 2009 Schedule

4:10 p.m. EST Q4 & FY 2008 results will be distributed by PRNewswire

4:50 p.m. EST To participate in the conference call, dial 913-661-9178 and refer to Conference Code Number 9540364

5:00 p.m. EST Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on "Investor Information," then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EST, February 19, 2009. To listen to the audio replay, dial 1- 719-457-0820 and use the Conference Code Number 9540364.

Additional information presented on the conference call may be made available on the Investor Information page of the company's website.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference
2. Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
3. Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
4. Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
5. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
6. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
7. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
8. Cephalon Conference Call Invitation
9. Cephalon Reports Strong First Quarter Earnings
10. Cephalon Appoints Gerald J. Pappert as General Counsel
11. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... , ... Curemark, LLC announced today that the Blüm Study, a Phase 3 ... with Autism, is now enrolling at three new sites. These new sites are in ... , “There are currently no approved drugs that address the core symptoms of autism,” ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... athletics. It’s enough to overwork even the sharpest brain. , Power On, a ... healthy activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, a ...
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of ... with the April 2017 testing period. NACCM, a nonprofit organization, has provided the ... (CMC) exam is periodically re-calibrated to ensure that newly certified professionals are prepared ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... just as effective on smaller and sometimes harder to reach ones, according to ... presented at the International Stroke Conference in Houston by Ricardo A. Hanel, MD, ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... celebrated throughout the country today, as organizations, advocates, and individuals join together to ... and treatment access to ultimately save lives. , “Today we mark a nationwide ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 22, 2017 Summary ... partnering deals and agreements entered into by the ... report: http://www.reportlinker.com/p03605669-summary/view-report.html Description The Global ... report provides understanding and access to partnering deals ... healthcare companies. - Trends in partnering ...
(Date:2/22/2017)... -- General Report Contents - Market Analyses include: ... - Market Drivers & Limiters for each chapter ... - Section on recent mergers & acquisitions ... This market comprises three product segments ... fiber-delivered lasers and direct delivery lasers. Products that ...
(Date:2/22/2017)... Calif., Feb. 22, 2017  Ultra Clean Holdings, ... of critical systems and subsystems for the semiconductor ... industries, today reported its financial results for the ... 2016. "2016 was a year of ... revenue reached record highs and together with continued ...
Breaking Medicine Technology: